Clinical Trial Update: Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating glutamine supplementation to prevent death or infection in extremely premature infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Birth Weight
• Neonatal Sepsis
• Premature Birth
• Small For Gestational Age

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 3 | Status: COMPLETED